AdAlta: A big development for fibrosis sufferers … and it could be lucrative too

Listen to ASX-listed AdAlta Managing Director Tim Oldham talk to Matt Birney on the Bulls N’ Bears Report about AdAlta’s extraordinary new drug that just might be a game changer for fibrosis sufferers. 

AdAlta: A big development for fibrosis sufferers … and it could be lucrative too
Listen to ASX-listed AdAlta Managing Director Tim Oldham talk to Matt Birney on the Bulls N’ Bears Report about AdAlta’s extraordinary new drug that just might be a game changer for fibrosis sufferers.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement